GSA Capital Partners’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,751
| Closed | -$31K | – | 2003 |
|
|
2022
Q3 | $31K | Sell |
1,751
-6,264
| -78% | -$111K | ﹤0.01% | 1440 |
|
|
2022
Q2 | $178K | Buy |
8,015
+4,453
| +125% | +$98.9K | 0.03% | 1103 |
|
|
2022
Q1 | $99K | Buy |
3,562
+2,987
| +519% | +$83K | 0.01% | 1294 |
|
|
2021
Q4 | $26K | Buy |
+575
| New | +$26K | ﹤0.01% | 1355 |
|
|
2019
Q2 | – | Sell |
-734
| Closed | -$123K | – | 1804 |
|
|
2019
Q1 | $123K | Sell |
734
-45
| -6% | -$7.54K | 0.01% | 1313 |
|
|
2018
Q4 | $85K | Buy |
+779
| New | +$85K | 0.01% | 1235 |
|
|
2018
Q3 | – | Sell |
-79
| Closed | -$170K | – | 1977 |
|
|
2018
Q2 | $170K | Hold |
79
| – | – | 0.01% | 1563 |
|
|
2018
Q1 | $197K | Buy |
+79
| New | +$197K | 0.01% | 1475 |
|
|
2014
Q3 | – | Sell |
-17
| Closed | -$32K | – | 1974 |
|
|
2014
Q2 | $32K | Buy |
+17
| New | +$32K | ﹤0.01% | 1764 |
|